Galderma

We’re very proud to see Lainey Lei, Head of Galderma China, recognized on Fortune China’s 2024 "Most Influential Women in Business" list, an annual ranking of the most impactful female leaders shaping China’s business landscape. Lainey was honored for her strategic vision and leadership excellence, having led Galderma China to rapid growth and significant milestones since she became General Manager in 2020. Galderma continues on a strong growth trajectory in China, with notable progress in both Injectable Aesthetics and Dermatological Skincare so far in 2024. A recent milestone was the approval of Sculptra in China, one of the world’s fastest-growing aesthetics markets - further enhancing our portfolio in a region where demand continues to expand. Congratulations to Lainey on this recognition, and to the entire Galderma China team for their dedication! https://lnkd.in/eJddiXU4 #Leadership #China

Though 99% of dermatology residents recognize the importance of learning about sensitive skin, less than 30% report being very knowledgeable on the subject.     As part of the Derm Club podcast series on Galderma’s Global Sensitive Skin Faculty (GSSF), Pr. Adam Friedman and Erika McCormick, MD speak about the sensitive skin knowledge gap.     The GSSF bridges this gap by researching, innovating and educating. It exists to empower the sensitive skin community—from patients to healthcare providers—with data-driven and actionable insights.    Drawing from Pr. Friedman and Dr. McCormick’s research at George Washington University, this episode looks at how far sensitive skin science has come – and how far it has to go.     Listen to episode three here:  https://lnkd.in/dzTBDnvV   #AdvancingDermatology #GSSF #SensitiveSkin #DermClub

 Wrapping up an incredible two days at GAIN JPAC! This year's theme, ‘Embarking on the NEXT Aesthetic Journeys,’ celebrated the uniqueness of each patient and the influence of pop culture, innovative treatments, and evolving views on aging from the six emerging trends from our NEXT by Galderma report. A thank you to all of our experts for leading insightful discussions and demonstrations, and to our amazing attendees for their active participation. Your dedication to expanding knowledge and honing injection skills is what drives outstanding results for patients! For more updates on Galderma and to stay connected with the global aesthetics community, follow @GAINbyGalderma on Instagram. #GAINJPAC #GAIN2024

This weekend at the GAIN JPAC, “Embarking on the NEXT Aesthetic Journeys” event in Incheon, our outstanding faculty delivered a powerful mix of expertise, techniques, and unique perspectives. We are deeply grateful to them for raising the bar in the aesthetics industry and fostering a strong sense of community – both globally and within their local regions. Our distinguished speakers include Dr. Andreas Nikolis, Dr. Stephanie Lam, Dr. Gi-Woong Hong, Dr. Jeff Huang, Dr. Malavika Kohli, Dr. Van Park, Dr. Maria Cristina Puyat, Dr. Andy Qian Luo, Dr. Richard Rassameechote and Dr. Belinda Welsh. #GAINJPAC #GAIN2024 #AdvancingDermatology

What can be expected NEXT in aesthetics around the globe? Our NEXT by Galderma trends report launched earlier this year identified six emerging trends that are shaping patient demands and clinical practices worldwide. We had the opportunity to connect with some of our esteemed speakers — Dr. Stephanie Lam, Dr. Andreas Nikolis, Dr. Van Park and Dr. Richard Rassameechote to discuss how they are applying these trends in their practices, how they’ve evolved, and their cultural relevance in the clinic setting. #NEXTbyGalderma #AdvancingDermatology #Galderma #GAINJPAC

We're celebrating 25 years of science, stories and innovation with Sculptra®, our flagship brand of injectable biostimulator. For over twenty years, Sculptra®, the first proven regenerative biostimulator, has been helping patients achieve naturally radiant, firm skin by stimulating their own production of collagen and elastin. At our GAIN JPAC event in Incheon, we celebrated this milestone with over 650 attendees and delegates from the Asia Pacific region. At Galderma, we're committed to pushing the boundaries of dermatology, and we wish Sculptra® an exceptional 25th anniversary around the world! #GAINJPAC #GAIN2024  #Sculptra25

The CTMP® (Cleanse, Treat, Moisturize, Protect) skincare program and the effects skin quality can have on quality of life are a main focus of our attention at Galderma. Skin quality is influenced by a combination of different aspects and varies according to each individual. Identifying key factors such as firmness, discoloration and texture helps to create a long-term, holistic treatment plan. The CTMP® holistic skincare program, developed by experts, creates an ideal foundation for the skin, delivering the best possible results from aesthetic treatments. Tomorrow at our GAIN JPAC event in Incheon, our esteemed faculty, Dr. Malavika Kohli and Dr. Belinda Welsh will dive deeper into these trending topics. Aesthetic practitioners, make sure to follow us on Instagram at @GAINbyGalderma for more exclusive updates from GAIN JPAC and other events! #AdvancingDermatology #GAINJPAC #GAIN2024

We've officially kicked off GAIN JPAC 2024 in Incheon, where we'll be welcoming over 650 leading aesthetic professionals from across the Asia Pacific region.  Special thanks to Francie Tan, Desislava Lazarova, MD and our CEO Dr. Flemming Ornskov, MD, MPH for joining us live on Galderma's Instagram account. GAIN is the leading global provider of education for injectable aesthetics, rooted in science, and created by practitioners for practitioners. Over the course of the weekend, our attendees and experts will explore the latest advances in aesthetics, focusing on the six key emerging trends highlighted in our NEXT by Galderma trends report. We believe that these trends will shape the future of the industry. Our faculty will delve deep into each of these trends during dedicated sessions and will share actionable insights. Dermatologists and aesthetic practitioners, get further updates on GAIN events by following @GAINbyGalderma on Instagram - aimed at the aesthetic community around the world. #GAINJPAC #GAIN2024 #AdvancingDermatology #NEXTbyGalderma

With one of the highest demands for aesthetics, the Asia Pacific region houses some of Galderma’s fastest growing markets, where sales have fueled the company’s strong performance across product categories. This weekend, Galderma will be convening a new edition of the Galderma Aesthetic Injector Network (GAIN), bringing together the largest number of professionals to date.    Recognizing the uniqueness of each patient and the influence that factors such as pop culture, rising treatments, and the perspective of aging have on aesthetics, our theme for this year is ‘Embarking on the NEXT Aesthetic Journeys’ following the launch of our NEXT by Galderma trends report earlier this year. Over the course of two days, our esteemed faculty as well as attendees will share their insights to support the aesthetics community in delivering the most relevant and holistic individualized treatments to patients.   Get the latest updates on GAIN JPAC and other Galderma portfolio news by following @GAINbyGalderma on Instagram - intended for global aesthetic practitioners among the Galderma community.  Read the full article here: https://bit.ly/3YnfQrC #GAINJPAC #GAIN2024 #AdvancingDermatology

Innovation progress marked the third quarter of 2024 for Galderma: we achieved the highest net sales in our history. We delivered $3.259 B USD in net sales during the year’s first nine months, with broad-based growth across all product categories. In Injectable Aesthetics, our biostimulators platform continued its strong growth trajectory, supported by the successful launch of Sculptra® in Thailand earlier this year. Growth in our Dermatological Skincare business was driven by flagship brands Cetaphil® and Alastin®, with Alastin launching in Brazil and Colombia. And in Therapeutic Dermatology, we brought to market in the U.S. our novel biologic for adult patients with prurigo nodularis. Learn more about our Q3 milestones: https://lnkd.in/dDur7kmr #AdvancingDermatology #Q3results #GALD